Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

A visual guide to the Ebola virus epidemic

As the 2014 Ebola virus epidemic continues to escalate, we chart the latest epidemiological data alongside an insight into the pathology of Ebola virus disease and the biological processes being targeted by drug and vaccine developers.

As the 2014 Ebola virus epidemic continues to escalate, we chart the latest epidemiological data alongside an insight into the pathology of Ebola virus disease and the biological processes being targeted by drug and vaccine developers.

Source: National Institutes of Health / NIAID / Science Photo Library

Timeline

Six months into the outbreak and the virus has spread to five countries in West Africa. Although cases in Nigeria, Senegal and Guinea appear to have stabilised, cases in Liberia and Sierra Leone continue to rise.

Timeline of the ebola outbreak in West Africa in 2014

Transmission and symptoms

Ebola virus enters the patient through mucous membranes, broken skin, or parenterally. The virus exerts its effects directly, by causing cell necrosis, and indirectly, by causing apoptosis (programmed cell death). Apoptosis is prompted by the release of cytokines from infected cells. The virus infects many cell types, including monocytes, macrophages, dendritic cells, endothelial cells, fibroblasts, hepatocytes, adrenal cortical cells and epithelial cells. Although lymphocytes are not infected, they undergo apoptosis.

Ebola virus symptoms and transmission and its effects on the human body

A) Fever, headache and chills are caused by the host mounting an overt immune (cytokine) response to the Ebola virus.

B) Bleeding from the eyes, ears and mouth is caused by loss of vascular integrity due to endothelial cell death and dysregulation of clotting factors because of hepatocellular necrosis.

C) Impaired kidney and liver function is caused by death of renal and hepatic cells infected by the virus; there may also be some level of apoptosis in these tissues.

D) The virus evades the immune response by causing rapid destruction of lymphoid tissue, including B and T cells, and disrupting the interferon response.

E) Severe watery diarrhoea, nausea, vomiting and abdominal pain is likely to be caused by necrotic infection of the gastrointestinal tract, resulting in loss of the ciliated cells required for absorption of nutrients. The physical damage leads to gastrointestinal bleeding and the other gastrointestinal symptoms.

F) Muscle pain and weakness is likely to be due to the host immune (cytokine) response to the virus.

G) Haemorrhagic rash over the entire body, bruising, and oozing from venipuncture sites is caused by loss of vascular integrity due to endothelial cell death and dysregulation of clotting factors because of hepatocellular necrosis.

The biology

Ebola virus attaches to the cell surface and is internalised, subsequently releasing its genetic material into the host cell cytoplasm. The RNA genome of the virus is transcribed into seven mRNAs, which are translated into the viral proteins. Some of these proteins then aid replication of the viral genome while others are destined to become the viral coating. New viral particles are then assembled from the replicated genome and new coat proteins and these bud from the cell.

Biology of the Ebola virus

Biology of the Ebola virus

 

Country characteristics

The West African countries worst affected by the outbreak have poorly developed health systems, with little public health infrastructure and few healthcare professionals. The last bar in each chart allows comparison with the UK.

Doctors per 1,000 population (West Africa versus UK)

Doctors per 1,000 population. Liberia has the lowest density of doctors at just 1 in 71,429 of the population.

Nurses and midwives per 1,000 population (West Africa versus UK)

Nurses and midwives per 1,000 population. Sierra Leone has the lowest number of nurses and midwives, at 1 for every 6,024 people.

Pharmaceutical personnel per 1,000 population (West Africa versus UK)

Pharmaceutical personnel per 1,000 population. Senegal has only one pharmacy worker for every 100,000 people.

Population density per square kilometre (West Africa versus UK)

Population density per square kilometre. Nigeria has the highest population density of countries affected but also by far the highest density of medical professionals.

Government expenditure on health per capita ($US) (West Africa versus UK)

Government expenditure on health per capita ($US). The combined per capita spend of the affected countries is less than 4% of that of the UK.

 

 

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20066664

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • As the 2014 Ebola virus epidemic continues to escalate, we chart the latest epidemiological data alongside an insight into the pathology of Ebola virus disease and the biological processes being targeted by drug and vaccine developers.
  • Timeline of the ebola outbreak in West Africa in 2014
  • Ebola virus symptoms and transmission and its effects on the human body
  • Biology of the Ebola virus
  • Doctors per 1,000 population (West Africa versus UK)
  • Government expenditure on health per capita ($US) (West Africa versus UK)
  • Nurses and midwives per 1,000 population (West Africa versus UK)
  • Pharmaceutical personnel per 1,000 population (West Africa versus UK)
  • Population density per square kilometre (West Africa versus UK)

Supplementary information

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.